These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 348205)

  • 1. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
    Pozenel H
    Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)].
    Eckardt A; Koch W; Safer A
    Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)].
    Klein WW; Pavek P
    Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of meproscillarin on left ventricular hemodynamics (author's transl)].
    Pachinger O; Probst P
    Arzneimittelforschung; 1978; 28(3a):550-2. PubMed ID: 580587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose].
    Herken H; Brandes J
    Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the disposition of meproscillarin in rat and dog (author's transl)].
    Weymann J; Schenk G; Kesselring K
    Arzneimittelforschung; 1978; 28(3a):520-6. PubMed ID: 580582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)].
    Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I
    Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elimination of meproscillarin by hemoperfusion (author's transl)].
    Rupp M; Brass H; Belz GG
    Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of meproscillarin in man (author's transl)].
    Rietbrock N
    Arzneimittelforschung; 1978; 28(3a):540-5. PubMed ID: 580585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Labelling meproscillarin with tritium at the C-19 position (author's transl)].
    Schenk G; Albrecht HP; Lietz H
    Arzneimittelforschung; 1978; 28(3a):518-9. PubMed ID: 580581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the development of an oral preparation of meproscillarin (author's transl)].
    Einig H; Mayer D
    Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Med Klin; 1979 Nov; 74(47):1761-6. PubMed ID: 522817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
    Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
    Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of the cardiotonic effects of proscilaridine].
    Netto MP; Forti N; Formicola A; Chryssovergis G; Zillioto EE; Campanari JC; Lunardi W; Giannini SD
    Rev Hosp Clin Fac Med Sao Paulo; 1973; 28(6):300-4. PubMed ID: 4767562
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative measurement of pulmonary artery pressure after meproscillarin and beta-methyldigoxin demonstrating their effects on the left bentricular function in patients with heart and coronary insufficiency].
    Stauch M; Nissen N; Grewe N
    Arzneimittelforschung; 1978; 28(3a):545-50. PubMed ID: 580586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.